Clinical Trial Update: A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 single-dose cross-over clinical trial evaluating the direct and indirect effects of dapagliflozin on pancreatic alpha and beta cells in people with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Uppsala University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED